The Role of Androgens in Enhancing IVF Outcomes for Women with Low AMH

For many women, the journey through assisted reproductive technology is filled with challenges, particularly when they have low Anti-Müllerian Hormone (AMH) levels. Low AMH levels can significantly reduce the chances of a successful IVF cycle. Patients often ask about the clinical benefits of taking supplements known as androgens, such as Dehydroepiandrosterone (DHEA) and testosterone, or they may start using them without advice after reading online information.

Following on from our blog on the importance of evidenced based medicine, we highlight

key insights from the Human Fertilisation and Embryology Authority (HFEA) Scientific and Clinical Advances Advisory Committee who rate treatment add ons according to the available evidence.

You can read the HFEA review here.

Using any supplement or medication involves a certain level of risk. Patients are bombarded with commercial information online and often rely on anecdotal accounts of benefits. It is important to use the available scientific evidence to determine if the potential benefits outweigh any risks to make fully informed choices.